Total Clarity Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,000
Closed -$215K – 242
2022
Q3
$215K Sell
4,000
-250
-6% -$12.8K 0.13% 200
2022
Q2
$171K Sell
4,250
-300
-7% -$14.9K 0.09% 230
2022
Q1
$301K Sell
4,550
-100
-2% -$6.84K 0.17% 166
2021
Q4
$465K Buy
4,650
+10
+0.2% +$1.03K 0.21% 107
2021
Q3
$580K Hold
4,640
– – 0.28% 91
2021
Q2
$576K Sell
4,640
-20
-0.4% -$2.69K 0.32% 91
2021
Q1
$711K Hold
4,660
– – 0.41% 60
2020
Q4
$601K Buy
4,660
+120
+3% +$13.8K 0.42% 67
2020
Q3
$507K Hold
4,540
– – 0.44% 62
2020
Q2
$368K Sell
4,540
-150
-3% -$12.1K 0.34% 85
2020
Q1
$326K Hold
4,690
– – 0.5% 65
2019
Q4
$366K Buy
+4,690
New +$338K 0.27% 79

Other funds holding GH

Total Clarity Wealth Management's GH Position: Q4 2022 in Review

Total Clarity Wealth Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,000 shares — an estimated $215K sold.

Total Clarity Wealth Management first reported a position in GH in Q4 2019 and held it in 12 quarters. The position peaked at $711K in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Total Clarity Wealth Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 4,000 Guardant Health shares in Q4 2022, an estimated $215K.
  • Total Clarity Wealth Management first reported a position in Guardant Health in Q4 2019 and held it in 12 quarters.
  • Total Clarity Wealth Management's Guardant Health position peaked at $711K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Total Clarity Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.